C.M. Bidwell & Associates »

Entrada Therapeutics shares owned by C.M. Bidwell & Associates

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by C.M. Bidwell & Associates from 13F filings

Historical chart of C.M. Bidwell & Associates investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by C.M. Bidwell & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by C.M. Bidwell & Associates

Quarter filed Position value Share count Share price at filing
2024-12-31 $3.7k 212 17.29
2024-09-30 $462 29 15.97

More positions owned by C.M. Bidwell & Associates

Vanguard Short-Term Bond ETF (BSV)
iShares Russell 1000 Index (IWB)
iShares Russell 2000 Index (IWM)
Vanguard Total Stock Market ETF (VTI)
Vanguard S&p 500 Etf idx (VOO)
iShares Brclys Intrdte Gov/Crt Bd (GVI)
Ishares Tr core strm usbd (ISTB)
Vanguard Malvern Fds strm infproidx (VTIP)
Vanguard Total Bond Market ETF (BND)
iShares MSCI ACWI ex US Index Fund (ACWX)
Vanguard Europe Pacific ETF (VEA)
Vanguard Intermediate-Term Bond ETF (BIV)
Dimensional Etf Trust (DFAC)
Vanguard Mun Bd Fd Inc tax-exempt bd (VTEB)
Schwab Strategic Tr us lrg cap etf (SCHX)

View all positions for C.M. Bidwell & Associates

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
MPM Asset Management
T. Rowe Price Associates
Henderson Group
BlackRock
Vanguard Group
FMR
Wellington Management Company
StepStone
TCG Crossover Management
Geode Capital Management
State Street Corporation
Northern Trust
Goldman Sachs Group

View all funds holding Entrada Therapeutics